	Evaluating the efficacy and safety of antibody-drug conjugates in non-small cell lungÂ cancer: a systematic review andÂ meta-analysis. BMC Cancer Zhang L, Jia H, Niu B. PMID: 41545863 [PubMed - as supplied by publisher]
	Robotic-assisted thoracic surgery for resectable lung cancer: efficacy, safety and surgical approaches - an umbrella review of meta-analyses. BMC Surg Xu Y, Han Q, Wang C, Xu J, Li X, Zhang Q. PMID: 41545856 [PubMed - as supplied by publisher]
	Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial. Signal Transduct Target Ther Wang M, Liu W, Guo H, Long H, Yu B, Zhao G, Wu J, Yue D, Zhao X, Li C, Zhang L, Wang S, Zhang Q, Zhang Z, Wang C. PMID: 41545337 [PubMed - indexed for MEDLINE]
	Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC. J Immunother Cancer Onieva JL, Pérez-Ruiz E, Figueroa-Ortiz LC, Jurado JM, Martínez B, Carlos Benítez J, Rueda-Domínguez A, Barragán I. PMID: 41545302 [PubMed - indexed for MEDLINE]
	Next-generation lung-cancer-on-a-chip: toward personalized therapy, AI, and CRISPR-driven models. Drug Discov Today Hossain NS, Tasnim N, Ferdoush J, Roy A, Saha SC, Saha A. PMID: 41544897 [PubMed - as supplied by publisher]
	Telomere Length Dynamics As a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiotherapy. Int J Radiat Oncol Biol Phys Zhai T, Toprani SM, Dillon-Martin M, Doyle PF, Kang H, Novack C, Liang L, Christiani DC, Kozono DE, Nagel ZD. PMID: 41544677 [PubMed - as supplied by publisher]
	Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial. Lancet Lu S, Wang J, Yang N, Lv D, Chen L, Wu L, Li X, Sun L, Yu Y, Jin B, Yang L, Guo Y, Xu H, Yi T, Zeng A, Dong X, Chen J, Wang Z, Niu H, Cheng Y, Pan P, Deng P, Pan H, Min X, Bai J, Liu L, Zhang T, Li J, Fan S, Shi MM, Mok T, Su W, SACHI Study Group. PMID: 41544643 [PubMed - as supplied by publisher]
	Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib. Clin Lung Cancer Tomasini P, Juan-Vidal O, Califano R, Lin CC, Hulo P, Dooms C, Fang J, Blasco A, Kowalski D, Salinas J, Babu G, Mun TL, Bearz A, Surmont V, Baldotto C, Sharma R, Arrieta O, Stencel K, Card C, Zer A, Massarelli E, Fang B, Mashru S, Schuchard J, Sermon J, Diels J, Chu PL, Withelder M, Bauml JM, Shah S, Baig M, Felip E. PMID: 41544603 [PubMed - as supplied by publisher]
	Adaptive and migration-enhanced tree seed algorithm for multi-threshold CT image segmentation and lung cancer recognition. PLoS One Li C, Jiang J, Ma Z, Yu Z, Li H, Liu J, Li L, Yu Z. PMID: 41544119 [PubMed - indexed for MEDLINE]
	Immunotherapy after EGFRâ€‘TKI treatment in advanced nonâ€‘small cell lung cancer: Current status and future perspectives (Review) . Oncol Rep Ma H, Li L, Jiao C, Cheng Y, He J, Jiang C, Tong Q, Yi D, Zhang Y. PMID: 41543165 [PubMed - indexed for MEDLINE]
	Letter to the Editor: Association Between Immunotherapy and Overall Survival in Malnourished Patients with Advanced Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan. Nutr Cancer Li N, Chen H, Wang Y, Li X. PMID: 41542856 [PubMed - as supplied by publisher]
	Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report. Cancer Rep (Hoboken) Nigi A, Kumasa T, Iwamoto K, Itani H, Kondou S, Uraki J. PMID: 41542718 [PubMed - indexed for MEDLINE]
	General practitioners' attitudes towards liquid biopsy as a diagnostic test for advanced lung cancer. J Liq Biopsy Lo D, Wong J, Keenan R, Fingleton J, Wong ANM. PMID: 41541744 [PubMed]
	Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer. iScience Zhu L, Jia X, Xu L, Chen L, Fu X, Yan H, Ai B, Peng S. PMID: 41541668 [PubMed]
	Burden of lung cancer and application of patient-reported outcomes in the Western Pacific Region: a systematic analysis. Front Med (Lausanne) Liu K, Gao Q, Wang X, Lan J, Tian T, Rong H. PMID: 41541505 [PubMed]
	Interventions targeted to improve lung cancer screening uptake among high-risk individuals: A systematic review and meta-analysis. Asia Pac J Oncol Nurs Yang Y, Zhao W, Chan DNS, Zhou S, Choi KC, So WKW. PMID: 41541011 [PubMed]
	Study of Imaging Analysis for Distinguishing Alveolar Collapse From Invasive Lesions in Early-Stage Lung Adenocarcinoma. Thorac Cancer Kaneda S, Ito A, Ito D, Kawaguchi T, Takao M, Kawaguchi K. PMID: 41540808 [PubMed - indexed for MEDLINE]
	Evolving Patterns of Care, Outcomes and Ongoing Challenges for Early-Stage Non-Small Cell Lung Cancer in the Immunotherapy Era: A Queensland Population-Based Study. Thorac Cancer Chan BA, Youlden DR, Pattison A, Guan T, Cossio D, Sanmugarajah J. PMID: 41540800 [PubMed - indexed for MEDLINE]
	Textbook outcome and long-term survival after pulmonary resection for non-small cell lung cancer: a retrospective cohort study. World J Surg Oncol Raykateeraroj N, Chu F, Suh JM, Petterlin L, Francis E, Zhao J, Ratnayakemudiyanselage P, Navaz FAP, Ker CJ, Roshanaei S, Botta H, Elias J, Ling E, Ma R, Barnett SA, Knight S, Lee DK, Weinberg L. PMID: 41540440 [PubMed - as supplied by publisher]
	High endothelial venules abundance in tertiary lymphoid structures: a prognostic biomarker in non-small cell lung cancer with neoadjuvant immunochemotherapy. BMC Cancer Zhang Y, Xie M, Gao J, Ma X, Yao J, Lin X, Bao X, Zhang X, Li K, Du A, Wei B, Zang X, Xue X. PMID: 41540369 [PubMed - as supplied by publisher]

Articles 1 - 20 / 155668

Page 1 of 7784



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy